Heart Disease News and Research

Latest Heart Disease News and Research

Balloon pump use prior to PCI does not reduce infarct size in STEMI patients without shock

Intra-aortic balloon pump counterpulsation prior to PCI in patients with ST segment elevation MI does not reduce infarct size as measured by MRI, according to results from the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction (CRISP AMI) trial.

30 Aug 2011

Study: Gender gap has not diminished in reperfusion therapy

In spite of an increased attention to gender differences in treatment of myocardial infarctions, focus on adherence to guidelines and a change in predominant therapy, the gender difference in treatment and mortality regarding the big infarctions - STEMI - has not diminished from 1998-2000 to 2004-2006. For some therapies, it has actually increased.

30 Aug 2011

AstraZeneca: BRILIQUE receives Class I recommendation from ESC

AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."

30 Aug 2011

Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress

A phase II dose-finding study has found that the new oral Factor Xa inhibitor darexaban was associated with a two to four-fold increase in bleeding when added to dual antiplatelet therapy in patients following an acute coronary syndrome.

30 Aug 2011

Intra-aortic balloon counterpulsation prior to PCI does not reduce infarct size in AMI patients

Inserting intra-aortic balloon pumps prior to angioplasty in patients with acute myocardial infarction (AMI) does not reduce the scope of heart muscle damage, a condition referred to as infarct size, according to a new study conducted by Duke University Medical Center researchers.

30 Aug 2011

An advance toward using stem cells in 'regenerative medicine'

With stem cells so fickle and indecisive that they make Shakespeare's Hamlet pale by comparison, scientists today described an advance in encouraging stem cells to make decisions about their fate.

30 Aug 2011

Educational program about cardiovascular prevention in children can reduce parents' CVD risk

"A multidisciplinary educational programme in cardiovascular prevention directed to children of school age can reduce their parents' cardiovascular risk. Cardiovascular prevention could have more success focusing on children first, inducing healthier lifestyle habits in the whole family, "said investigator Luciana Fornari, from the University of Sao Paulo, Brazil.

30 Aug 2011

Everolimus-eluting stent reduces incidence of stent thrombosis

Results of the independently-funded Bern-Rotterdam cohort study provide robust evidence of an "important" reduction in overall and very late stent thrombosis.

30 Aug 2011

Remote follow-up of ICD patients seems to be a safe alternative to conventional in-office methods

Results from the EVATEL trial are the first in Europe to demonstrate potential safety and efficacy benefits from the remote follow-up of ICD patients.

30 Aug 2011

UHC Supply Chain helps University of Iowa Hospitals and Clinics to save $14M in 18 months

A supply chain strategy built on excellence in customer service and a partnership with UHC Supply Chain has helped UHC member University of Iowa Hospitals and Clinics initiate 35 projects that saved more than $14 million in 18 months.

30 Aug 2011

New chemical compounds show promise against set of protein-folding diseases

Collaborating researchers at Stanford University and The Scripps Research Institute have identified chemical compounds that show promise as potential therapeutics for a set of medical conditions caused by the abnormal clumping together of a protein known as transthyretin.

30 Aug 2011

Study indicates large gap in use of proven therapies for heart attack or stroke

A global study in 17 countries led by McMaster University researchers has found too few patients are using drugs proven to give significant benefits in warding off a heart attack or stroke.

30 Aug 2011

Researchers demonstrate benefits of 8-week 'Beating Heart Problems' group programme

Researchers from the Heart Research Centre in Melbourne, Australia, have demonstrated the benefits of the 8-week 'Beating Heart Problems' group programme in a randomised controlled trial.

30 Aug 2011

Study finds higher incidence of arrhythmias in elite cross-country skiers

A Swedish study presented at the ESC Congress 2011 today, found a higher incidence of arrhythmias in cross-country skiers with a long history of endurance training.

30 Aug 2011

Clinical trial to evaluate RMN system for treatment of ischemic Ventricular Tachycardia

Results from the STOP-VT Study were presented at the ESC Congress 2011 today. This is the first ever multi-center, global, prospective trial to evaluate a Remote Magnetic Navigation system for the treatment of ischemic Ventricular Tachycardia.

30 Aug 2011

St. Michael's Echocardiography and Vascular Laboratory receives ICAEL accreditation

The Echocardiography and Vascular Laboratory at St. Michael's Hospital has been recognized for its commitment to quality patient care and testing for heart and vascular disease.

30 Aug 2011

Ivabradine reduces heart volume among patients with cardiac insufficiency

As guest speaker at the European Society of Cardiology's Congress currently under way in Paris, Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute's Research Centre and professor of medicine at the Universit- de Montr-al, today presented the results of an analysis demonstrating that ivabradine, a medication used to reduce heart rate, also reduces heart volume (left ventricle) among patients with cardiac insufficiency.

30 Aug 2011

Bristol Meyer Squibb’s new blood thinner drug for stroke prevention

Researchers find that an experimental anticlotting pill Eliquis is more effective than standard drug, warfarin, at preventing strokes in people with a heart condition that puts them at high risk of blood clots and stroke. The new drug also known as apixaban, cut the risk of stroke by 21% compared with warfarin in people with atrial fibrillation (AF). It lowered the risk of dying by 11%.

30 Aug 2011

Chocolate for the heart - benefits revealed

A comprehensive analysis of previous studies including more than 114,000 subjects has shown that high levels of chocolate consumption are associated with a significant reduction in the risk of certain cardiovascular disorders.

30 Aug 2011

Post myocardial infarction snus quitters have 44% lower risk of mortality

In this prospective cohort study, presented today at the ESC Congress 2011, discontinuation of smokeless tobacco after a myocardial infarction (MI) is associated with a lower risk of subsequent mortality. Investigators found that post MI snus quitters had a 44 % lower risk of total mortality.

29 Aug 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Balloon pump use prior to PCI does not reduce infarct size in STEMI patients without shock

Study: Gender gap has not diminished in reperfusion therapy

AstraZeneca: BRILIQUE receives Class I recommendation from ESC

Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress

Intra-aortic balloon counterpulsation prior to PCI does not reduce infarct size in AMI patients

An advance toward using stem cells in 'regenerative medicine'

Educational program about cardiovascular prevention in children can reduce parents' CVD risk

Everolimus-eluting stent reduces incidence of stent thrombosis

Remote follow-up of ICD patients seems to be a safe alternative to conventional in-office methods

UHC Supply Chain helps University of Iowa Hospitals and Clinics to save $14M in 18 months

New chemical compounds show promise against set of protein-folding diseases

Study indicates large gap in use of proven therapies for heart attack or stroke

Researchers demonstrate benefits of 8-week 'Beating Heart Problems' group programme

Study finds higher incidence of arrhythmias in elite cross-country skiers

Clinical trial to evaluate RMN system for treatment of ischemic Ventricular Tachycardia

St. Michael's Echocardiography and Vascular Laboratory receives ICAEL accreditation

Ivabradine reduces heart volume among patients with cardiac insufficiency

Bristol Meyer Squibb’s new blood thinner drug for stroke prevention

Chocolate for the heart - benefits revealed

Post myocardial infarction snus quitters have 44% lower risk of mortality

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in